AI Article Synopsis
- - Six strains of multiresistant Klebsiella pneumoniae, which produce the NDM-1 enzyme, were found during an outbreak affecting neonatal patients in a Colombian hospital.
- - Molecular examination revealed that all strains contained the blaNDM-1, qnrA, and intI1 genes and shared a close genetic relationship.
- - These strains represent a new sequence type (ST1043) never documented before, marking the first identification of NDM-1-producing bacteria in South America.
Article Abstract
Six multiresistant, NDM-1-producing Klebsiella pneumoniae strains were recovered from an outbreak that affected six neonatal patients in a Colombian hospital. Molecular analysis showed that all of the isolates harbored the blaNDM-1, qnrA, and intI1 genes and were clonally related. Multilocus sequence typing showed that the isolates belonged to a new sequence type (ST1043) that was different from the sequence types that had previously been reported. This is the first report of NDM-1-producing isolates in South America.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623329 | PMC |
| http://dx.doi.org/10.1128/AAC.01447-12 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Identification of NDM-1 producing and colistin resistant Klebsiella pneumoniae ST11: A highly drug-resistant strain detected in intensive care unit of a Greek tertiary care hospital.
Acta Microbiol Immunol Hung
January 2025
1Department of Biomedical Sciences, Faculty of Health Sciences, International Hellenic University, 57400 Thessaloniki, Greece.
The spread of NDM-1-harboring Klebsiella pneumoniae is a worldwide concern. In this study the whole-genome sequence (WGS) of a carbapenem- and colistin-resistant K. pneumoniae 838Gr strain is presented.
View Article and Find Full Text PDFCarbapenemase-Producing Enterobacterales from Patients Arriving from Ukraine in Poland, March 2022-February 2023.
Infect Dis Ther
January 2025
Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Chełmska 30/34, 00-725, Warsaw, Poland.
Introduction: Despite a scarcity of data, before 2022 Ukraine was already considered a high-prevalence country for carbapenemase-producing Enterobacterales (CPE), and the situation has dramatically worsened during the full-scale war with Russia. The aim of this study was to analyse CPEs isolated in Poland from victims of war in Ukraine.
Methods: The study included 65 CPE isolates from March 2022 till February 2023, recovered in 36 Polish medical centres from 57 patients arriving from Ukraine, differing largely by age and reason for hospitalisation.
Genomic and phylogenetic analysis of a NDM-1 producing ST152 Klebsiella pneumoniae isolated from a bloodstream infection in China.
J Glob Antimicrob Resist
November 2024
Department of Clinical Laboratory, The Quzhou Affiliated Hospital of Wenzhou Medical University, Quzhou People's Hospital, Quzhou, China. Electronic address:
Article Synopsis
- The study focused on analyzing the genomic structure of the first isolated ST152 Klebsiella pneumoniae strain carrying the bla gene in China.
- Various methods, including antimicrobial susceptibility testing and whole-genome sequencing, were utilized to investigate the strain's resistance patterns and genetic features.
- Results showed that the strain is resistant to multiple antibiotics but sensitive to tigecycline and colistin, and it is genetically related to strains from other regions, highlighting concerns about antibiotic resistance transmission.
Outbreak caused by multidrug-resistant OXA-48 and NDM-1 producing Klebsiella pneumoniae in the intensive care unit of a cancer hospital.
Acta Microbiol Immunol Hung
September 2024
1Department of Clinical Microbiology, University of Health Sciences Dr. Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital, Ankara, Turkey.
We report a nosocomial outbreak caused by a multidrug-resistant carbapenemase-producing Klebsiella pneumoniae (MDRCPKp), that was detected in six patients admitted to the medical intensive care unit between 20th of December 2023 and 15th of January 2024 in Ankara, Turkey. The investigation of this outbreak was started on 29th of December 2023. During the outbreak 11 samples were collected from the six patients with MDRCPKp.
View Article and Find Full Text PDFMolecular Characterization of a KPC-2- and NDM-1-Producing Clinical Isolate in Cerebrospinal Fluid.
Infect Drug Resist
August 2024
Department of Clinical Laboratory, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, People's Republic of China.
Article Synopsis
- A strain named fxq was isolated from a cerebrospinal fluid sample of a patient with tentorial meningioma, showcasing resistance to carbapenems due to the presence of KPC and NDM carbapenemase genes.
- Identification methods included the Phoenix 100 system, MALDI-TOF, and whole-genome sequencing, revealing that fxq is a novel sequence type (ST202) with specific plasmid characteristics.
- The study highlights the significant stability and transferability of the resistance plasmids, marking the first report of this particular resistant strain in a clinical setting.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!